References
Schottelius AJ, Moldawer LL, Dinarello CA, Asadullah K, Sterry W, Edwards CK III. Biology of tumor necrosis factor-a: implications for psoriasis. Exp Dermatol. 2004;13:193–222.
Collamer AN, Guerrero KT, Henning JS, Battafarano DF. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action. Arthritis Rheum. 2008;59:996–1001.
Ko JM, Gottlieb AB, Kerbleski JF. Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases. J Dermatolog Treat. 2009;20:100–8.
Bordel-Gómez M, Sánchez-Estella J, Martínez-González O, Cardenoso-Alvarez ME. Palmoplantar psoriasis: a paradoxical adverse reaction induced by adalimumab. J Eur Acad Dermatol Venereol. 2009;23:444–5.
Schmidt E, Wetter DA, Ferguson SB, Pittelkow MP. Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-a inhibitors: the Mayo Clinic experience, 1998 to 2010. J Am Acad Dermatol. 2011;67(5):e179–85. doi:10.1016/j.jaad.2011.05.038.
Ritchlin C, Tausk F. A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents. Ann Rheum Dis. 2006;65:1541–5.
Tobin AM, Kirby B. TNFa inhibitors in the treatment of psoriasis and psoriatic arthritis. BioDrugs. 2005;19:47–57.
Lahfa M, Mrowietz U, Koenig M, Simon JC. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis. Eur J Dermatol. 2003;13:261–5.
Werner de Castro GR, Neves FS, Pereira IA, Fialho SC, Ribeiro G, Zimmermann AF. Resolution of adalimumab-induced psoriasis after vitamin D deficiency treatment. Rheumatol Int. 2012;32:1313–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Korkmaz, U., Duman, A.E., Dindar, G. et al. Adalimumab-induced psoriasis in a patient with Crohn’s disease. Indian J Gastroenterol 32, 135–136 (2013). https://doi.org/10.1007/s12664-012-0281-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12664-012-0281-2